Glecaprevir / Pibrentasvir

Phenobarbital

Not recommended association.

Available pharmaceutical opinion

Document made available to the pharmacist to communicate a drug interaction to the doctor.

DOWNLOAD
Mechanism

Phenobarbital may induce CYP 3A4 and P-gp and decrease the plasma concentration of .

Glecaprevir / Pibrentasvir

Pharmacodynamic effects

Possible decrease of clinical efficacy.

Recommendations

Alternative solution(s)

Phenobarbital

Pharmacodynamic effects

Recommendations

Avoid association.

Alternative solution(s)

Monitor

Tests

Pharmacokinetic parameters

Comment

See glecaprevir/pibrentasvir + carbamazepine.

Reference
  • 3373
    Glecaprevir/Pibrentasvir (Maviret), Abbvie, Québec, Canada, 19 février 2020.